Sertraline, chlorprothixene, and chlorpromazine characteristically interact with the REST-binding site of the corepressor mSin3, showing medulloblastoma cell growth inhibitory activities

Scientific Reports
Jun-Ichi KuritaYoshifumi Nishimura

Abstract

Dysregulation of repressor-element 1 silencing transcription factor REST/NRSF is related to several neuropathies, including medulloblastoma, glioblastoma, Huntington's disease, and neuropathic pain. Inhibitors of the interaction between the N-terminal repressor domain of REST/NRSF and the PAH1 domain of its corepressor mSin3 may ameliorate such neuropathies. In-silico screening based on the complex structure of REST/NRSF and mSin3 PAH1 yielded 52 active compounds, including approved neuropathic drugs. We investigated their binding affinity to PAH1 by NMR, and their inhibitory activity toward medulloblastoma cell growth. Interestingly, three antidepressant and antipsychotic medicines, sertraline, chlorprothixene, and chlorpromazine, were found to strongly bind to PAH1. Multivariate analysis based on NMR chemical shift changes in PAH1 residues induced by ligand binding was used to identify compound characteristics associated with cell growth inhibition. Active compounds showed a new chemo-type for inhibitors of the REST/NRSF-mSin3 interaction, raising the possibility of new therapies for neuropathies caused by dysregulation of REST/NRSF.

References

Sep 1, 1985·Journal of Neuropathology and Experimental Neurology·P F JacobsenJ M Papadimitriou
Nov 1, 1995·Journal of Biomolecular NMR·F DelaglioA Bax
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y NaruseN Mori
Feb 13, 2003·Journal of the American Chemical Society·Cyril DominguezAlexandre M J J Bonvin
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Jul 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Alexander W BruceNoel J Buckley
Feb 4, 2005·Protein Science : a Publication of the Protein Society·Kengo Kinoshita, Haruki Nakamura
Jun 14, 2005·Journal of Molecular Graphics & Modelling·Yoshifumi FukunishiHaruki Nakamura
Sep 26, 2006·Journal of Chemical Information and Modeling·Yoshifumi FukunishiHaruki Nakamura
Mar 24, 2007·Progress in Neurobiology·Chiara Zuccato, Elena Cattaneo
Jun 19, 2007·Nature Reviews. Genetics·Lezanne Ooi, Ian C Wood
Aug 9, 2007·Nature Reviews. Molecular Cell Biology·Francesco PampaloniErnst H K Stelzer
Apr 15, 2008·Bioorganic & Medicinal Chemistry·Samantha LeoneAlessandro Contini
Dec 3, 2008·Journal of Molecular Graphics & Modelling·Yoshifumi Fukunishi, Haruki Nakamura
Dec 4, 2008·Statistical Applications in Genetics and Molecular Biology·Kim-Anh Lê CaoPhilippe Besse
Aug 27, 2009·Bioinformatics·Kim-Anh Lê CaoSébastien Déjean
Oct 21, 2009·Journal of Child Neurology·Girish Dhall
Nov 17, 2009·Biochemical Society Transactions·Angela BithellNoel J Buckley
Feb 23, 2010·Neurobiology of Disease·Noel J BuckleyElena Cattaneo
Apr 2, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hitoshi UchidaHiroshi Ueda
May 1, 2010·Nature Protocols·Sjoerd J de VriesAlexandre M J J Bonvin
Nov 11, 2010·Protein Science : a Publication of the Protein Society·Yoshifumi Fukunishi, Haruki Nakamura
Mar 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Rajeevan SelvaratnamGiuseppe Melacini
Mar 31, 2011·Journal of Biomolecular NMR·Beomsoo HanDavid S Wishart
Jan 10, 2012·Stem Cells·Mohamed M KamalSadhan Majumder
Aug 15, 2012·Journal of Cheminformatics·Marcus D HanwellGeoffrey R Hutchison
Oct 2, 2012·Annual Review of Pharmacology and Toxicology·Vincent VialouEric J Nestler
Feb 19, 2013·Trends in Cell Biology·Sara NegriniJacopo Meldolesi
Apr 18, 2013·Analytical and Bioanalytical Chemistry·Olivier CalaIsabelle Krimm
Nov 20, 2013·International Journal of Molecular Sciences·Edward C Lauterbach
Jul 13, 2014·Journal of Biomolecular NMR·Aleksandar AntanasijevicMichael Caffrey
Apr 22, 2015·Nucleic Acids Research·Jianguo XiaDavid S Wishart

❮ Previous
Next ❯

Citations

Jan 8, 2020·International Journal of Molecular Sciences·Jose M Garcia-ManteigaJacopo Meldolesi
Jun 20, 2020·Acta Biochimica Et Biophysica Sinica·Ming MaJian Fei
Nov 28, 2020·Current Treatment Options in Oncology·Hussein HammoudSanaa Nabha
Jul 16, 2021·Oncotarget·Pareesa Kamgar-Dayhoff, Tinatin I Brelidze

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR
PCA
X-ray
gel-filtration

Software Mentioned

- DA
eF
CNS
sPLA
HADDOCK
MixOmics
sPCA
Sievgene
UFF
cosgene

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here